Peer Review reports
From: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases
| Original Submission | ||
|---|---|---|
| 30 Aug 2018 | Submitted | Original manuscript |
| 22 Sep 2018 | Reviewed | Reviewer Report - Chi-Lu Chiang |
| 22 Sep 2018 | Reviewed | Reviewer Report - Sreenivasan Sasidharan |
| 21 Oct 2018 | Author responded | Author comments - Wan Ling Tan |
| Resubmission - Version 2 | ||
| 21 Oct 2018 | Submitted | Manuscript version 2 |
| 11 Nov 2018 | Author responded | Author comments - Wan Ling Tan |
| Resubmission - Version 3 | ||
| 11 Nov 2018 | Submitted | Manuscript version 3 |
| 19 Nov 2018 | Author responded | Author comments - Wan Ling Tan |
| Resubmission - Version 4 | ||
| 19 Nov 2018 | Submitted | Manuscript version 4 |
| Publishing | ||
| 20 Nov 2018 | Editorially accepted | |
| 3 Dec 2018 | Article published | 10.1186/s12885-018-5110-2 |
You can find further information about peer review here.